@incollection{, AA58AA4A9A3944C064572C2B7DFBDAA7 , author={{Shoyusuf F.Shodmanov} and {Shakhnoza Z.Umarova} and {Zoya R.Usmanova}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}2234146 } @incollection{b0, , title={{The role of systematic review and meta-analysis in the evaluation of technologies in health care}} , author={{ SJalalov } and { Ch } and { DJalalova } and { Kh } and { DSKhoch }} , journal={{Medical Technology: Evaluation and Choice}} 3 , year={2012} } @incollection{b1, , title={{Effects of Tafluprost treatment for 3 years in patients with normal-tension glaucoma}} , author={{ IwasaInoue } and { Tomita }} , journal={{Clinical Ophthalmology}} 7 , year={2013} } @incollection{b2, , title={{Effects of Travoprost treatment for 3 years in patients with normal-tension glaucoma}} , author={{ IwasaInoue } and { TomitaWakakura }} , journal={{Clinical Ophthalmology}} 6 , year={2012} } @incollection{b3, , title={{Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma}} , author={{ GCBrown } and { MMBrown }} 10.1089/jop.2018.01145.Nice , journal={{Journal of ocular pharmacology and therapeutics}} , year={2019. 2017. January 2020} , note={Glaucoma: Diagnosis and management. London: National Institute for Health and Care Excellence (UK)} } @book{b4, , title={{Conceptualization of a model for medical technology assessment. Medical technology assessment and selection}} , author={{ SJalalov } and { Ch } and { DJalalova } and { Kh } and { DSKhoch }} , year={2014} } @book{b5, , title={{Economic evaluation and modeling of healthcare technologies}} , author={{ SDzhalalov } and { Ch } and { DDzhalalova } and { Kh } and { MKran } and { DKhoch }} 59 , note={Tashkent. 2020} } @incollection{b6, , title={{The Economic Burden of Major Adult Visual Disorders in the United States}} , author={{ DBRein }} 10.1001/archopht.124.12.1754 , journal={{Archives of Ophthalmology}} 124 12 , year={2006. Accessed 12 December 2019} } @incollection{b7, , title={{Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery}} , author={{ PLichter }} 10.1016/s0161-6420(01)00873-9 , journal={{Ophthalmology}} 108 11 , year={2001. January 2020} } @incollection{b8, , title={{Diagnosis and Management of Chronic Open Angle Glaucoma and Ocular Hypertension. London: National Collaborating Center for Acute Care}} , author={{ AHeijl }} 10.1001/archopht.120.10.1268 , journal={{Archives of Ophthalmology}} 120 10 , year={2002. 20 January 2020. 2009. Accessed 20 January 2020} , note={Reduction of Intraocular Pressure and Glaucoma Progression} } @incollection{b9, , title={{Uzbekistan. World Health Organization}} , journal={{World Health Organization}} , year={2016. Accessed 20 January 2020} } @incollection{b10, , title={{The Impact of Anchor Point on Utilities for 5 Common Ophthalmic Diseases}} , author={{ BSLee }} 10.1016/j.ophtha.2007.06.008 , journal={{The American Academy of Ophthalmology}} 115 5 , year={2008. 20 January 2020} } @incollection{b11, , title={{Does the type of treatment have an influence on utility values in a glaucoma population}} , author={{ RPaletta Guedes } and { VPaletta Guedes } and { SFreitas } and { AChaoubah }} 10.2147/opth.s92653 , journal={{Clinical Ophthalmology}} , year={2015. 20 January 2020} } @incollection{b12, , title={{Guidelines for the treatment of glaucoma of the International Council of Ophthalmology (ICO)}} , journal={{International Council of Ophthalmology}} , year={2016. 20 January 2020} , note={San Francisco: ICO} } @incollection{b13, , title={{The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration}} , author={{ ALiberati }} doi:10.1136/ bmj.b2700 , journal={{BMJ}} , year={2009. 20 January 2020} , note={jul21 1} }